Comparison of the Clinical Efficacy of Quinolones, β- lactams Combined with Quinolones and Carbapenems in the Empirical Treatment of Severe Community Acquired Pneumonia
GUO Lin-hong, ZHANG Ming-guo, GAO Ge, et al. Comparison of the Clinical Efficacy of Quinolones, β- lactams Combined with Quinolones and Carbapenems in the Empirical Treatment of Severe Community Acquired Pneumonia[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(4): 488-492.
[1] 瞿介明,曹彬.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(04):253-279. [2] OLSON G,DAVIS A M.Diagnosis and treatment of adults with community-acquired pneumonia[J].JAMA,2020,323(9):885-886. [3] 胡付品,郭燕,朱德妹,等.2019年CHINET三级医院细菌耐药监测[J].中国感染与化疗杂志,2020,20(3):233-243. [4] 国家卫生计生委. 抗菌药物临床应用指导原则(2015年版)[EB/OL].(2015-07-24) http://www.gov.cn/foot/site1/20150827/9021440664034848.pdf. [5] WONG C K,LAI V,WONG Y C.Comparison of initial high resolution computed tomography features in viral pneumonia between Metapneumovirus infection and severe acute respiratory syndrome[J].Eur J Radiol,2012,81(5):1083-1087. [6] 曾永保,何林波,尹春梅,等.283例重症社区获得性肺炎患者支气管肺泡灌洗液病原菌分布及药敏分析[J].药物流行病学杂志,2017,26(7):485-489. [7] 李坤. 亚胺培南与莫西沙星治疗重症肺炎的临床疗效及对炎性因子水平的影响[J].中国现代药物应用,2020,14(5):141-143. [8] 郭晓宁,赵正煜,何巍,等.三种经验性抗感染方案用于社区获得性肺炎的疗效及对患者炎症状态的影响[J].中国医院用药评价与分析,2020,20(3):293-296. [9] KARHU J,ALA-KOKKO T I,VUORINEN T,et al.Interleukin-5,interleukin-6,interferon induced protein-10,procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients[J].Cytokine,2019,113:272-276.